ARDX (STOCKS)
Ardelyx, Inc.
$7.330000
+0.030000 (+0.41%)
Prev close: $7.300000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael G. Raab
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,762.78M
- Employees
- 395
- P/E (TTM)
- -30.65
- P/B (TTM)
- 11.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
10
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.00 | $-0.06 | +0.0589 | +100.00% |
|
Jun 2025 (Q2)
|
$-0.08 | $-0.14 | +0.0562 | +41.26% |
|
Mar 2025 (Q1)
|
$-0.17 | $-0.12 | -0.0541 | -46.68% |
|
Dec 2024 (Q4)
|
$0.02 | $0.00 | +0.0153 | +325.53% |
Financial Statements
| Revenues | $398.23M |
| Benefits Costs and Expenses | $453.78M |
| Cost Of Revenue | $46.95M |
| Costs And Expenses | $389.23M |
| Gross Profit | $351.28M |
| Nonoperating Income/Loss | $9.08M |
| Operating Expenses | $389.23M |
| Selling, General, and Administrative Expenses | $326.90M |
| Research and Development | $62.34M |
| Operating Income/Loss | -$37.95M |
| Income/Loss From Continuing Operations After Tax | -$56.55M |
| Income/Loss From Continuing Operations Before Tax | -$55.55M |
| Income Tax Expense/Benefit | $997.00K |
| Net Income/Loss | -$56.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$56.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$56.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.23 |
| Diluted Earnings Per Share | -$0.23 |
| Basic Average Shares | 240,882,366 |
| Diluted Average Shares | 240,882,366 |
| Assets | $486.17M |
| Current Assets | $367.99M |
| Inventory | $129.36M |
| Other Current Assets | $238.63M |
| Noncurrent Assets | $118.19M |
| Fixed Assets | $2.07M |
| Other Non-current Assets | $116.12M |
| Liabilities | $331.89M |
| Current Liabilities | $83.39M |
| Accounts Payable | $18.39M |
| Wages | $15.06M |
| Other Current Liabilities | $49.94M |
| Noncurrent Liabilities | $248.50M |
| Long-term Debt | $202.14M |
| Other Non-current Liabilities | $46.36M |
| Equity | $154.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $154.28M |
| Liabilities And Equity | $486.17M |
| Net Cash Flow From Operating Activities | -$53.62M |
| Net Cash Flow From Operating Activities, Continuing | -$53.62M |
| Net Cash Flow From Investing Activities | -$54.36M |
| Net Cash Flow From Investing Activities, Continuing | -$54.36M |
| Net Cash Flow From Financing Activities | $103.27M |
| Net Cash Flow From Financing Activities, Continuing | $103.27M |
| Net Cash Flow | -$4.71M |
| Net Cash Flow, Continuing | -$4.71M |
| Comprehensive Income/Loss | -$56.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$56.61M |
| Other Comprehensive Income/Loss | -$56.61M |